STXS CIK: 1289340

Stereotaxis, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
23.2
FY22:
18.5
FY23:
14.9
FY24:
14.6
FY25:
17.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.9
FY22:
−18.8
FY23:
−21.8
FY24:
−24.7
FY25:
−22.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.0
FY22:
−18.3
FY23:
−21.2
FY24:
−23.8
FY25:
−20.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.7
FY22:
−18.3
FY23:
−20.7
FY24:
−24.0
FY25:
−21.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.7
FY22:
−18.3
FY23:
−20.7
FY24:
−24.0
FY25:
−21.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data